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Background: Maternal antibodies can interfere with foot-and-mouth disease vaccination. In this study we deter-
mined whether intratypic heterologous vaccination could help to improve herd immunity.
Results: In unvaccinated calves, a half-life of maternal antibodies of 21 days was determined. At two weeks of age,
calves without maternal antibodies showed a good antibody response against both vaccines used in the trial, while
in calves with maternal antibodies no antibody response to homologous vaccination (A Turkey 14/98) but a limited
antibody response to intratypic heterologous vaccination (A22 Iraq) was observed.
Conclusion: Two weeks old calves without maternal antibodies respond well to vaccination, but when emergency
vaccination is carried out in a region that uses prophylactic vaccination, using an intratypic heterologous vaccine
strain may improve the immunity in calves with maternal antibodies.
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Maternal antibodies against foot-and-mouth disease virus
(FMDV) interfere with vaccination [1-3]. This interference
is not unique for FMDV but is seen in many diseases and
can cause the occurrence of a serious immunity gap in
young animals of a population. This immunity gap is due
to waning levels of maternal antibodies and poor response
to vaccination in the presence of maternal antibodies.
In the case of canine distemper, a solution to overcome
this immunity gap was the use of measles virus, a
related Morbillivirus, for the vaccination of newborn
puppies. Vaccination with measles virus could induce
active immunity against canine distemper in the presence
of maternal antibodies against canine distemper. However,
although in vaccination trials a good response was seen,
the vaccine was less successful in field conditions [4].* Correspondence: Aldo.Dekker@wur.nl
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unless otherwise stated.Prophylactic vaccination against FMDV is often prac-
tised in endemically infected areas. Also here, the
immunity gap in young animals needs special attention.
Outbreaks in countries that use prophylactic vaccination
are often seen in areas or in age groups with poor im-
munity against the disease. Emergency vaccination around
the observed outbreaks can improve protection against
FMDV. However, prophylactic vaccination is usually not
applied before the age of 3–4 months [1]. However, in an
outbreak situation, emergency vaccination has to start
immediately and one cannot wait till the young animals
have reached the age that normally would be considered
optimal for vaccination. But then maternal antibodies will
interfere with the response. Then the use of an intratypic
heterologous vaccine in order to overcome the effect of
maternal antibodies might be considered.
Such a situation occurred during the FMDV outbreak in
Turkish Trace in early 2006. All dams had previously been
vaccinated with an FMDV type A IRN/96 (or similar
strain). The 2006 FMDV outbreak strain, however, showedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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was included in the emergency vaccine. Normally, young
cattle would be vaccinated after levels of maternal anti-
bodies had sufficiently declined. But here the question was
raised whether calves with maternal antibodies against A
IRN/96 would respond to the A22 Iraq strain used in the
emergency vaccine, because this strain was heterologous
in respect to the maternal antibodies. Based on the results
with measles and canine distemper described above, it was
advised to vaccinate all ruminants irrespective of age.
To elucidate whether the given advice was sound, we
investigated whether intratypic heterologous vaccination
using A22 Iraq could successfully induce an antibody
response in young calves and especially if born from
dams vaccinated against A Turkey 14/98 (that falls
within the A IRN/96 lineage).
Methods
The animal experiments received approval of the animal
ethics committee of the Central Veterinary Institute in
accordance with the Dutch law ("wet op de dierproe-
ven"). The animals were housed and fed according to the
standard operating procedures at the animal facilities of
the Central Veterinary Institute, which is similar to the
housing on farms in the Netherlands. All cows and
calves were conventionally reared full and mixed breed
Holstein Frisians. Calves were assigned to 5 groups of 5
calves (Table 1). The first 15 calves (groups 1 to 3) were
fed with colostrum obtained from 15 cows that had been
used in a vaccine safety trial. To make sure that the birth
vaccination interval was similar and vaccination in each
group could be performed on the same day, we assigned
the first 5 calves born to group 1, the next 5 calves to
group 2 and the last 5 calves to group 3. Calves in group
4 and 5 arrived on the same day and were randomly
assigned to the groups. The dams provided the colos-
trum to their own calves, but of a few dams a part of the
colostrum was frozen. If a calf died it was replaced by a
colostrum deprived one day old calf, which was fed with
the colostrum stored in the freezer. The dams that pro-
vided colostrum to the calves in groups 1, 2 and 3, had
been vaccinated three times with a trivalent (A Turkey
14/98, O Manisa, Asia-1 Shamir) Cedivac-FMD vaccine
[5], one time in each trimester of pregnancy. Calves used
in groups 4 and 5 were born from non-vaccinated dams.Table 1 Experimental design (5 calves in each group)
Group Maternal antibodies Cedivac-FMD vaccine
1 Yes A Turkey 14/98
2 Yes A22 Iraq
3 Yes None
4 No A Turkey 14/98
5 No A22 IraqCalves of groups 1, 2, 4 and 5 were vaccinated two to
three weeks after birth. The calves in groups 1 and 4
were vaccinated subcutaneously with 2 ml of a monova-
lent homologous Cedivac-FMD vaccine containing strain
A Turkey 14/98 and the calves in groups 2 and 5 were
vaccinated similarly with a heterologous monovalent
Cedivac-FMD vaccine containing strain A22 Iraq (Table 1).
The formulation (antigen dose and adjuvant) of both
vaccines were similar. Serum samples were collected on
a weekly basis up to 6 weeks after vaccination and
tested for virus neutralising antibodies against FMDV
type A22 Iraq, A Turkey 14/98, O1 Manisa and Asia 1
Shamir, using BHK cells (performed according tot the
OIE manual, www.oie.int).
Two-fold dilutions of the serum samples were tested
starting with undiluted serum. For calculation of the mean
titres and for the use in statistical tests we used 0 for the
observations with a log10 titre of <0.30. To calculate the
r1-value [6] between the FMDV strains A Turkey 14/98
and A22 Iraq, we used the geometric mean titres of the
serum samples collected at 3 weeks post-vaccination from
the calves without maternal antibodies (groups 4 and 5).
The relation between neutralising antibody titre in the
dams 4 weeks after the last vaccination (approximately
30 weeks of gestation) and the antibody titre in the calves
just after colostrum uptake was analysed by least-square
regression.
The decrease of maternal antibodies and the effect of
the different vaccination strategies was analysed using a
linear mixed effects model, because of the repeated
sampling of the same calves. In this linear mixed effects
model, animal was the random variable, the neutralising
antibody titre was the response variable and age, sero-
type and group the possible explanatory variables. By
using the animal as random variable, parallel regression
lines per calf can be estimated as not all calves start with
the same titre. In this analysis neutralising antibody
titres <0.3 were excluded, as we were only interested in
the part of the curve that could be measured. Using a
forward stepwise method the various explanatory vari-
ables were introduced into the model. The best fitting
model was selected based on the AIC. All the statistical
analyses were performed using R (www.r-project.org)
version 2.14.2 [7]. For the linear mixed effects model,
the lme4 library was used [8].
Results
Maternal antibodies
A total of 4 calves died in the first 14 days after birth, 1
calf in group 2 and 3 calves in group 3; these calves were
replaced with other calves that were subsequently fed
with colostrum from one of the vaccinated dams. In the
11 calves that survived, the amount of maternal anti-
bodies varied between calves (Figure 1). Although uptake
Figure 1 Relation between neutralising antibody titre (log10) in
the dams 2 weeks after the last vaccination (approximately
30 weeks of gestation) and the antibody titre in the calves just
after colostrum uptake.
Table 2 Estimates, standard error and t-value of the fixed
effects in the final linear mixed effects model explaining
the neutralising antibody titres in the calves with maternal
antibodies
Estimate Standard error t-value
Intercept 2.7 0.15 18
Strain O Manisa Reference
Strain Asia-1 Shamir −0.21 0.039 −5.3
Strain A Turkey 14/98 −0.93 0.040 −23
Age −0.014 0.000083 −17
Figure 2 Average neutralising antibody titres against A Turkey
14/98 observed in serum samples from calves vaccinated with
monovalent A Turkey 14/98 vaccine (red) or with A22 Iraq
vaccine (blue) and from the non-vaccinated calves with maternal
antibodies (green). The average neutralising antibody titres of the
groups with maternal antibodies (group 1, 2 and 3) are shown with
a solid line. The average neutralising antibody titres of the calves
without maternal antibodies (group 4 and 5) are shown a dashed
line. The bars represent the standard error of the mean; to prevent
overlapping error-bars the lines are slightly displaced.
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analysis of the neutralising antibody titre observed in the
dam and the offspring showed that the magnitude of the
maternal antibody titre in healthy calves correlated with
the neutralising antibody titre of the dam. The response in
the dams and therefore in the calves, varied for the differ-
ent strains. Statistically there was no significant difference
in the slope of the relation between neutralising antibody
titre of the dams and their calves. For all three serotypes
combined, the slope of the relation between neutralising
antibody titre in the dam and the calf was 1.1 and the
intercept −0.5 (R-squared 0.72, Figure 1).
Half-life maternal antibodies
The analysis of the mixed linear effects model of the
observed maternal antibody titres of groups 1, 2 and 3
for all 3 FMDV serotypes included in the vaccine showed
that the observed maternal antibody titre was explained
by the serotype and the age of the calves (Table 2).
Although the level of antibodies was significantly differ-
ent between serotypes (p < < 0.001), no significant inter-
action between serotype and age was found. This means
that no difference in half-life of maternal antibodies was
observed between the serotypes. There was neither a
significant interaction between group and age which
means that there was no difference in half-life values
between the three groups of calves with maternal anti-
bodies. The latter shows that neither the vaccination
with strain A Turkey 14/98, nor strain A22 Iraq had aninfluence on the decrease of maternal antibodies. An
average half-life of 21 days was calculated (95% confi-
dence interval 19–24 days).
Vaccination response in the calves
The mean interval between birth and vaccination was
2.6, 2.3, 2.9 and 2.9 weeks for groups 1, 2, 4 and 5 re-
spectively (individually ranging from 2.0 to 3.3 weeks).
The two-three week old calves without maternal anti-
bodies showed a good homologous antibody response
after vaccination (dotted lines, groups 4 and 5 in re-
spectively Figures 2 and 3). The calves without maternal
Figure 3 Average neutralising antibody titres against A22 Iraq
observed in serum samples from calves vaccinated with
monovalent A Turkey 14/98 vaccine (red) or with A22 Iraq
vaccine (blue) and from the non-vaccinated calves with maternal
antibodies (green). The average neutralising antibody titres of the
groups with maternal antibodies (group 1, 2 and 3) are shown with
a solid line. The average neutralising antibody titres of the calves
without maternal antibodies (group 4 and 5) are shown a dashed
line. The bars represent the standard error of the mean; to prevent
overlapping error-bars the lines are slightly displaced.
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response against the heterologous type A; in all cases
heterologous titres at 3 week post vaccination were < 0.3.
This resulted in a mean r1-value of less than 0.1 for all
serum samples obtained from A Turkey 14/98 vacci-
nated calves when tested again A22 Iraq virus. And a
mean r1-value of 0.1 for the all A22 Iraq vaccinated
calves when tested with A Turkey 14/98 virus.
Calves born from vaccinated dams all had maternal anti-
body titres against A Turkey 14/98 that was included as
antigen in the vaccine of the dams (Figure 2). The calves
with maternal antibodies against A Turkey 14/98 did not
respond to homologous vaccination with A Turkey 14/98.
The average neutralising antibody titre against A Turkey
14/98 of group 1 (solid red line, Figure 2) is still decreasing
after vaccination of the calves and overlaps with the aver-
age neutralising antibody titre of the non-vaccinated calves
of group 3 (solid green line, Figure 2).
The calves with maternal antibodies against A Turkey
14/98 (group 2, solid blue line Figure 3) that were vacci-
nated with the heterologous strain A22 Iraq, however,
did respond to vaccination; their antibody titres are
significantly higher (p = 0.002) than the titres of the calves
with maternal antibodies against A Turkey 14/98 that
were not vaccinated (group 3, solid green line Figure 3).Discussion
While the experiment had originally been started as a
vaccine safety trial (the dams had been vaccinated three
times during pregnancy), it was decided to extend the
trial in order to examine whether FMD vaccination of
young calves makes sense in general and in particular,
whether an intratypic heterologous vaccine could induce
an antibody response in the presence of maternal anti-
bodies. In two-week old calves without maternal anti-
bodies, a good antibody response to both A Turkey 14/
98 as well as A22 Iraq (group 4 and 5, the dotted lines in
Figures 2 and 3) was observed. Obviously, the immune
system of calves is capable of responding to vaccination
already at this age. In contrast to calves without maternal
antibodies, calves with high levels of maternal antibodies
did not respond to vaccination with a homologous
vaccine, confirming earlier findings [1,3]. However, a
limited antibody response was seen after intratypic
heterologous vaccination in such calves. Apparently,
intratypic heterologous vaccination can, to some extent,
circumvent the inhibiting effect of maternal antibodies.
The experimental set-up well reflected a typical field situ-
ation. The neutralising antibody titres in the multiply-
vaccinated dams were high, but high neutralising antibody
titres may also be expected in infected dams, in which
case in their calves maternal antibodies can probably
be detected for more than 6 months. In the non-
vaccinated calves an average half-life of 21 days was
estimated, which corresponds very well with earlier
findings (22 days [3]).
Conclusion
This study shows that the immune system of calves is
capable of responding to vaccination at 2 weeks of age
and that intratypic heterologous FMDV vaccination can
circumvent the inhibiting effect of maternal antibodies
albeit to a limited level.
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